4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-002447
Sr VP/Chief Commercial Officer bought 2,114 shares at an average $4.53 ($9,571)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-01 | Purchase | +90 | $4.14 | $373 | 176,449 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-02 | Purchase | +90 | $3.84 | $346 | 176,539 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-03 | Purchase | +90 | $4.47 | $402 | 176,629 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-06 | Purchase | +90 | $4.46 | $401 | 176,719 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-07 | Purchase | +90 | $5.61 | $505 | 176,809 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-08 | Purchase | +90 | $6.15 | $554 | 176,899 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-09 | Purchase | +90 | $5.81 | $523 | 176,989 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-10 | Purchase | +90 | $4.82 | $434 | 177,079 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-13 | Purchase | +200 | $4.36 | $872 | 177,279 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-14 | Purchase | +200 | $4.28 | $856 | 177,479 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-15 | Purchase | +200 | $4.29 | $858 | 177,679 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-16 | Purchase | +240 | $4.53 | $1,087 | 177,919 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-17 | Purchase | +240 | $4.17 | $1,001 | 178,159 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-12-20 | Purchase | +314 | $4.33 | $1,360 | 178,473 | D |
| Open-market purchases · 2,114 sh · avg $4.53 · $9,571 | |||||||
Loading xslF345X03/doc4.xml…